Concepedia

Thomas Eichholtz

TE

Statistics

Publications

13

Citations

2.9K

H-Index

13

Active since

1989

Affiliations

The Netherlands Cancer Institute(Current)

University of British Columbia

GlaxoSmithKline (United Kingdom)

Wellcome Trust

Thomas Eichholtz is an author at The Netherlands Cancer Institute specializing in life sciences, cell signaling, and signal transduction.

Publications per year

1989–2006

13

Publications

13

Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins

E.J. van Corven, Alida Groenink, Kees Jalink et al. · Cell · 1989 · 846 citations

, , +7

The bioactive phospholipid lysophosphatidic acid is released from activated platelets

Thomas Eichholtz, Kees Jalink, Iris Fahrenfort et al. · Biochemical Journal · 1993 · 655 citations

, , +11

Rho and Rac but not Cdc42 regulate endothelial cell permeability

Beata Wójciak‐Stothard, Sandra Potempa, Thomas Eichholtz et al. · Journal of Cell Science · 2001 · 464 citations

, , +17

A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor.

Thomas Eichholtz, Dries B. de Bont, John de Widt et al. · Journal of Biological Chemistry · 1993 · 273 citations · Full text

, , +15

Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action.

Kees Jalink, Thomas Eichholtz, Friso R. Postma et al. · PubMed · 1993 · 213 citations

, , +15

1–5 of 13